13Indexed trials
drug · Product Intelligence
Pregabalin
Pipeline Intelligence
Pregabalin: 13 indexed trials, 8 sponsors; 0 linked Orange Book patents and 5 FDA-linked events where matched.
8Sponsors
0Orange Book patent links
5FDA-linked events
Development evidence
NCT00280059Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · epilepsyPHASE3
NCT00596466Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · epilepsyPHASE3
NCT00740571Radboud University Medical Center · pain_neuropathyPHASE3
NCT00994786McMaster University · ocdPHASE4
NCT01047488Odense University Hospital · pain_neuropathyPHASE4
NCT01049217Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · pain_neuropathyPHASE3
NCT01061697Singapore General Hospital · pain_neuropathyPHASE4
NCT01128712Northeast Regional Epilepsy Group · epilepsyPHASE4
NCT01262677Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · epilepsyPHASE3
NCT01271933Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · pain_neuropathyPHASE3
NCT01474772Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · pain_neuropathyPHASE3
NCT02673866Daiichi Sankyo · pain_neuropathyPHASE2
NCT06619860Vertex Pharmaceuticals Incorporated · pain_neuropathyPHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALPREGABALIN · 2024-01-24
FDA_APPROVALPREGABALIN · 2021-04-13
FDA_APPROVALPREGABALIN · 2020-03-23
FDA_APPROVALPREGABALIN · 2019-12-26
FDA_APPROVALPREGABALIN · 2019-11-29
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.